Diverse mechanisms of translation regulation and their role in cancer

Translation and Its Regulation in Cancer Biology and Medicine

Volumn , Issue , 2014, Pages 39-71

  Villa, Nancy ^a   Fraser, Christopher S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930897578     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-017-9078-9_3     Document Type: Chapter

References (219)

1. Anderson P, Kedersha N (2009) RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat Rev Mol Cell Biol 10:430-436
2. Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M (2008) Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol 10:1324-1332
3. Babendure JR, Babendure JL, Ding JH, Tsien RY (2006) Control of mammalian translation by mRNA structure near caps. RNA 12:851-861
4. Badhai J, Schuster J, Gidlof O, Dahl N (2011) 5?UTR variants of ribosomal protein S19 transcript determine translational efficiency: implications for Diamond-Blackfan anemia and tissue variability. PloS One 6:e17672
5. Balvay L, Soto Rifo R, Ricci EP, Decimo D, Ohlmann T (2009) Structural and functional diversity of viral IRESes. Biochim Biophys Acta 1789:542-557
6. Baranick BT, Lemp NA, Nagashima J, Hiraoka K, Kasahara N, Logg CR (2008) Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proc Natl Acad Sci U S A 105:4733-4738
7. Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D (2008) Suppression of myconcogenic activity by ribosomal protein haplo insufficiency. Nature 456:971-975
8. Berlanga JJ, Baass A, Sonenberg N (2006) Regulation of poly(A) binding protein function in translation: characterization of the Paip2 homolog, Paip2B. RNA 12:1556-1568
9. Bordeleau ME, Mori A, Oberer M, Lindqvist L, Chard LS, Higa T, Belsham GJ, Wagner G, Tanaka J, Pelletier J (2006) Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol 2:213-220
10. Buchan JR, Parker R (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36:932-941
11. Bushell M, Wood W, Clemens MJ, Morley SJ (2000) Changes in integrity and association of eukaryotic protein synthesis initiation factors during apoptosis. Eur J Biochem/FEBS 267:1083-1091
12. Calvo SE, Pagliarini DJ, Mootha VK (2009) Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc Natl Acad Sci U S A 106:7507-7512
13. Carlberg U, Nilsson A, Nygard O (1990) Functional properties of phosphorylated elongation factor 2. Eur J Biochem/FEBS 191:639-645
14. Chakraborty A, Uechi T, Kenmochi N (2011) Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway. Wiley Interdiscip Rev RNA 2:507-522
15. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200:640-646
16. Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY (2010) Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett 289:32-39
17. Chen L, Aktas BH, Wang Y, He X, Sahoo R, Zhang N, Denoyelle S, Kabha E, Yang H, Freedman RY et al (2012) Tumor suppression by small molecule inhibitors of translation initiation. Oncotarget 3:869-881
18. Clemens MJ, Bushell M, Morley SJ (1998) Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17:2921-2931
19. Cole MD, Cowling VH (2008) Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol 9:810-815
20. Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, Beyaert R (2000) Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell 5:597-605
21. Craig AW, Haghighat A, Yu AT, Sonenberg N (1998) Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature 392:520-523
22. Damgaard CK, Lykke-Andersen J (2011) Translational coregulation of 5?TOP mRNAs by TIA-1 and TIAR. Genes Dev 25:2057-2068
23. Damoc E, Fraser CS, Zhou M, Videler H, Mayeur GL, Hershey JW, Doudna JA, Robinson CV, Leary JA (2007) Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol Cell Proteomics 6:1135-1146
24. Dang CV (2012) MYC on the path to cancer. Cell 149:22-35
25. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24:2343-2364
26. De Benedetti A, Graff JR (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23:3189-3199
27. De Benedetti A, Rhoads RE (1990) Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci U S A 87:8212-8216
28. De Gregorio E, Preiss T, Hentze MW (1999) Translation driven by an eIF4G core domain in vivo. EMBO J 18:4865-4874
29. Decker CJ, Parker R (2012) P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol 4:a012286
30. Derry MC, Yanagiya A, Martineau Y, Sonenberg N (2006) Regulation of poly(A)-binding protein through PABP-interacting proteins. Cold Spring Harb Symp Quant Biol 71:537-543
31. Descamps G, Gomez-Bougie P, Tamburini J, Green A, Bouscary D, Maiga S, Moreau P, Le Gouill S, Pellat-Deceunynck C, Amiot M (2012) The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction. Br J Cancer 106:1660-1667
32. Ding F, Lavender CA, Weeks KM, Dokholyan NV (2012) Three-dimensional RNA structure refinement by hydroxyl radical probing. Nat Methods 9:603-608
33. Djuranovic S, Nahvi A, Green R (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336:237-240
34. Dmitriev SE, Terenin IM, Dunaevsky YE, Merrick WC, Shatsky IN (2003) Assembly of 48S translation initiation complexes from purified components with mRNAs that have some base pairing within their 5? untranslated regions. Mol Cell Biol 23:8925-8933
35. Donnelly N, Gorman AM, Gupta S, Samali A (2013) The eIF2alpha kinases: their structures and functions. Cell Mol Life Sci 70:3493-3511
36. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M (2006) S6K1-and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314:467-471
37. Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I, Ball S, Tchernia G, Klar J, Matsson H et al (1999) The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21:169-175
38. Duncan R, Milburn SC, Hershey JW (1987) Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4 F suggest a role in translational control. Heat shock effects on eIF-4 F. J Biol Chem 262:380-388
39. Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C, Wilson FH, Currie T, Khanna-Gupta A, Berliner N et al (2011) Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 117:2567-2576
40. Eberle J, Krasagakis K, Orfanos CE (1997) Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 71:396-401
41. Eulalio A, Behm-Ansmant I, Izaurralde E (2007) P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8:9-22
42. Feoktistova K, Tuvshintogs E, Do A, Fraser CS (2013) Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity. Proc Natl Acad Sci U S A 110:13339-13344
43. Flowers A, Chu QD, Panu L, Meschonat C, Caldito G, Lowery-Nordberg M, Li BD (2009) Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome. Surgery 146:220-226
44. Fraser CS, Doudna JA (2007) Structural and mechanistic insights into hepatitis C viral translation initiation. Natu Rev Microbiol 5:29-38
45. Freed EF, Bleichert F, Dutca LM, Baserga SJ (2010) When ribosomes go bad: diseases of ribosome biogenesis. Mol BioSyst 6:481-493
46. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K (1997) Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57:5041-5044
47. Gallie DR (1991) The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev 5:2108-2116
48. Gardner LB (2010) Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. Mol Cancer Res 8:295-308
49. Graff JR, Konicek BW, Vincent TM, Lynch RL, Monteith D, Weir SN, Schwier P, Capen A, Goode RL, Dowless MS et al (2007) Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117:2638-2648
50. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ (2005) c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7:311-318
51. Haghighat A, Sonenberg N (1997) eIF4G dramatically enhances the binding of eIF4E to the mRNA 5?-cap structure. J Biol Chem 272:21677-21680
52. Haines GK III, Becker S, Ghadge G, Kies M, Pelzer H, Radosevich JA (1993a) Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. Arch Otolaryngol Head Neck Surg 119:1142-1147
53. Haines GK, Ghadge GD, Becker S, Kies M, Pelzer H, Thimmappaya B, Radosevich JA (1993b) Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Archiv B Cell Pathology Incl Mol Pathol 63:289-295
54. Haines GK, Cajulis R, Hayden R, Duda R, Talamonti M, Radosevich JA (1996) Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol 17:5-12
55. Haines GK III, Panos RJ, Bak PM, Brown T, Zielinski M, Leyland J, Radosevich JA (1998) Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma. Tumour Biol 19:52-59
56. Hamilton TL, Stoneley M, Spriggs KA, Bushell M (2006) TOPs and their regulation. Biochem Soc Trans 34:12-16
57. Hannan KM, Brandenburger Y, Jenkins A, Sharkey K, Cavanaugh A, Rothblum L, Moss T, Poortinga G, McArthur GA, Pearson R.B et al (2003) mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol 23:8862-8877
58. Harris TE, Chi A, Shabanowitz J, Hunt DF, Rhoads RE, Lawrence JC, Jr (2006) mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J 25:1659-1668
59. Hellen CU, Sarnow P (2001) Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593-1612
60. Henis-Korenblit S, Shani G, Sines T, Marash L, Shohat G, Kimchi A (2002) The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins. Proc Natl Acad Sci U S A 99:5400-5405
61. Henras AK, Soudet J, Gerus M, Lebaron S, Caizergues-Ferrer M, Mougin A, Henry Y (2008) The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell Mol Life Sci 65:2334-2359
62. Hinnebusch AG (2005) Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol 59:407-450
63. Hinton TM, Coldwell MJ, Carpenter GA, Morley SJ, Pain VM (2007) Functional analysis of individual binding activities of the scaffold protein eIF4G. J Biol Chem 282:1695-1708
64. Hiremath LS, Webb NR, Rhoads RE (1985) Immunological detection of the messenger RNA capbinding protein. J Biol Chem 260:7843-7849
65. Holcik M (2004) Targeting translation for treatment of cancer-a novel role for IRES? Curr Cancer Drug Targets 4:299-311
66. Holz MK, Ballif BA, Gygi SP, Blenis J (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123:569-580
67. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, Shi EY, Stumpf CR, Christensen C, Bonham MJ et al (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485:55-61
68. Hughes TA (2006) Regulation of gene expression by alternative untranslated regions. Trends Genet 22:119-122
69. Iadevaia V, Caldarola S, Tino E, Amaldi F, Loreni F (2008) All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5?-terminal oligopyrimidine (TOP) mRNAs. RNA 14:1730-1736
70. Imataka H, Gradi A, Sonenberg N (1998) A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J 17:7480-7489
71. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS (2009) Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324:218-223
72. Ingolia NT, Lareau LF, Weissman JS (2011) Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147:789-802
73. Ingolia NT, Brar GA, Rouskin S, McGeachy AM, Weissman JS (2012) The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat Protoc 7:1534-1550
74. Jackson RJ (2013) The current status of vertebrate cellular mRNA IRESs. Cold Spring Harb Perspect Biol 5:a011569
75. Jackson RJ, Standart N (2007) How do microRNAs regulate gene expression? Sci STKE 2007:re1
76. Jager S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K et al (2012) Global landscape of HIV-human protein complexes. Nature 481:365-370
77. Jastrzebski K, Hannan KM, Tchoubrieva EB, Hannan RD, Pearson RB (2007) Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 25:209-226
78. Jia Y, Polunovsky V, Bitterman PB Wagner CR (2012) Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target. Med Res Rev 32:786-814
79. Kahvejian A, Svitkin YV, Sukarieh R, M'Boutchou MN, Sonenberg N (2005) Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev 19:104-113
80. Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, Fritzler MJ, Scheuner D, Kaufman RJ, Golan DE, Anderson P (2005) Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169:871-884
81. Kervestin S, Jacobson A (2012) NMD: a multifaceted response to premature translational termination. Nat Rev Mol Cell Biol 13:700-712
82. Khaleghpour K, Kahvejian A, De Crescenzo G, Roy G, Svitkin YV, Imataka H, O'Connor-Mc-Court M, Sonenberg N (2001a) Dual interactions of the translational repressor Paip2 with poly(A) binding protein. Mol Cell Biol 21:5200-5213
83. Khaleghpour K, Svitkin, YV, Craig, AW, DeMaria, CT, Deo, RC, Burley, SK, Sonenberg, N (2001b) Translational repression by a novel partner of human poly(A) binding protein, Paip2. Mol Cell 7:205-216
84. Kim SH, Forman AP, Mathews MB, Gunnery S (2000) Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19:3086-3094
85. Komar AA, Hatzoglou M (2011) Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle 10:229-240
86. Komar AA, Mazumder B, Merrick WC (2012) A new framework for understanding IRES-mediated translation. Gene 502:75-86
87. Koromilas AE, Lazaris-Karatzas A, Sonenberg, N (1992) mRNAs containing extensive secondary structure in their 5? non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 11:4153-4158
88. Kozak M (1986a) Bifunctional messenger RNAs in eukaryotes. Cell 47:481-483
89. Kozak M (1986b) Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci U S A 83:2850-2854
90. Kozak M (1986c) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292
91. Kozak M (1987a) An analysis of 5?-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125-8148
92. Kozak M (1987b) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196:947-950
93. Kozak M (1989) Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol Cell Biol 9:5134-5142
94. Kozak M (1991a) An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115:887-903
95. Kozak M (1991b) Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870
96. Kozak M (2001) Constraints on reinitiation of translation in mammals. Nucleic Acids Res 29:5226-5232
97. Kozak M (2005a) Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361:13-37
98. Kozak M (2005b) A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Res 33:6593-6602
99. Kressler D, Hurt E, Bassler J (2010) Driving ribosome assembly. Biochim Biophys Acta 1803:673-683
100. Lamphear BJ, Kirchweger R, Skern T, Rhoads RE (1995) Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem 270:21975-21983
101. Lankat-Buttgereit B, Goke R (2009) The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101:309-317
102. Lawson TG, Ray BK, Dodds JT, Grifo JA, Abramson RD, Merrick WC, Betsch DF, Weith HL, Thach RE (1986) Influence of 5? proximal secondary structure on the translational efficiency of eukaryotic mRNAs and on their interaction with initiation factors. J Biol Chem 261:13979-13989
103. Lazaris-Karatzas A, Sonenberg N (1992) The mRNA 5? cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. Mol Cell Biol 12:1234-1238
104. Lazaris-Karatzas A, Montine KS, Sonenberg N (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5? cap. Nature 345:544-547
105. Lee SH, Oh J, Park J, Paek KY, Rho S, Jang SK, Lee JB (2013) Poly(A) RNA and Paip2 act as allosteric regulators of poly(A)-binding protein. Nucleic Acids Res 42:2697-2707
106. LeFebvre AK, Korneeva NL, Trutschl M, Cvek U, Duzan RD, Bradley CA, Hershey JW, Rhoads RE (2006) Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit. J Biol Chem 281:22917-22932
107. Leung AK, Calabrese JM, Sharp PA (2006) Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci U S A 103:18125-18130
108. Lian Z, Pan J, Liu J, Zhang S, Zhu M, Arbuthnot P, Kew M, Feitelson MA (1999) The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene 18:1677-1687
109. Lian SL, Li S, Abadal GX, Pauley BA, Fritzler MJ, Chan EK (2009) The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing. RNA 15:804-813
110. Lipton JM, Ellis SR (2009) Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am 23:261-282
111. Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N, Hogg D (1999) Mutation of the CDKN2A 5? UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 21:128-132
112. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature Cell Biol 7:719-723
113. Loh PG, Yang HS, Walsh MA, Wang Q, Wang X, Cheng Z, Liu D, Song H (2009) Structural basis for translational inhibition by the tumour suppressor Pdcd4. EMBO J 28:274-285
114. Lu PD, Harding HP, Ron D (2004) Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 167:27-33
115. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q (2008) An analysis of human microRNA and disease associations. PLoS One 3:e3420
116. Lucks JB, Mortimer SA, Trapnell C, Luo S, Aviran S, Schroth GP, Pachter L, Doudna JA, Arkin AP (2011) Multiplexed RNA structure characterization with selective 2?-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq) Proc Natl Acad Sci U S A 108:11063-11068
117. Luft F (2010) The rise of a ribosomopathy and increased cancer risk. J Mol Med (Berl) 88:1-3
118. Luscher B, Vervoorts J (2012) Regulation of gene transcription by the oncoprotein MYC. Gene 494:145-160
119. Luteijn MJ, Ketting RF (2013) PIWI-interacting RNAs: from generation to transgenerational epigenetics. Nat Rev Genet 14:523-534
120. Mader S, Lee H, Pause A, Sonenberg N (1995) The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins Mol Cell Biol 15:4990-4997
121. Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK, Sonenberg N (2007) Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PloS One 2:e242
122. Maquat LE, Tarn WY, Isken O (2010) The pioneer round of translation: features and functions. Cell 142:368-374
123. Marcotrigiano J, Gingras AC, Sonenberg N, and Burley SK (1999) Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol Cell 3:707-716
124. Marintchev A (2013) Roles of helicases in translation initiation: a mechanistic view. Biochim Biophys Acta 1829:799-809
125. Marissen WE, Lloyd RE (1998) Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol Cell Biol 18:7565-7574
126. Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, Shyu AB, Imataka H, Gehring K, Sonenberg N (2008) Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol 28:6658-6667
127. Martineau Y, Azar R, Bousquet C, Pyronnet S (2013) Anti-oncogenic potential of the eIF4E-binding proteins. Oncogene 32:671-677
128. Masutani M, Sonenberg N, Yokoyama S, Imataka H (2007) Reconstitution reveals the functional core of mammalian eIF3. EMBO J 26:3373-3383
129. Masutani M, Machida K, Kobayashi T, Yokoyama S, Imataka H (2013) Reconstitution of eukaryotic translation initiation factor 3 by co-expression of the subunits in a human cellderived in vitro protein synthesis system. Protein Expr Purif 87:5-10
130. Matsuhashi S, Narisawa Y, Ozaki I, Mizuta T (2007) Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions. Exp Dermatol 16:179-184
131. McGlincy NJ, Smith CW (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci 33:385-393
132. McMahon R, Zaborowska I, Walsh D (2011) Noncytotoxic inhibition of viral infection through eIF4F-independent suppression of translation by 4EGi-1. J Virol 85:853-864
133. Meijer HA, Kong YW, Lu WT, Wilczynska A, Spriggs RV, Robinson SW, Godfrey JD, Willis AE, Bushell M (2013) Translational repression and eIF4A2 activity are critical for microRNAmediated gene regulation. Science 340:82-85
134. Methot N, Song MS, Sonenberg N (1996) A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3. Mol Cell Biol 16:5328-5334
135. Moeller BJ, Cao Y, Li CY, Dewhirst MW (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5:429-441
136. Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A, Gross JD, Degterev A, Yuan J, Chorev M et al (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128:257-267
137. Montanaro L, Trere D, Derenzini M (2012) Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta 1825:101-110
138. Moore CB, Guthrie EH, Huang MT, Taxman DJ (2010) Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown. Methods Mol Biol 629:141-158
139. Morino S, Imataka H, Svitkin YV, Pestova TV, Sonenberg N (2000) Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region. Mol Cell Biol 20:468-477
140. Morley SJ, McKendrick L, Bushell M (1998) Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogenactivated protein (MAP) kinase. FEBS Lett 438:41-48
141. Nakamura J, Aoyagi S, Nanchi I, Nakatsuka S, Hirata E, Shibata S, Fukuda M, Yamamoto Y, Fukuda I, Tatsumi N et al (2009) Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle. Int J Oncol 34:1181-1189
142. Nanbru C, Lafon I, Audigier S Gensac MC, Vagner S, Huez G, Prats AC (1997) Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem 272:32061-32066
143. Naranda T, Strong WB, Menaya J, Fabbri BJ, Hershey JW (1994) Two structural domains of initiation factor eIF-4B are involved in binding to RNA. J Biol Chem 269:14465-14472
144. Narla A, Ebert BL (2010) Ribosomopathies: human disorders of ribosome dysfunction. Blood 115:3196-3205
145. Nasr Z, Robert F, Porco JA Jr, Muller, WJ, Pelletier, J (2013) eIF4F suppression in breast cancer affects maintenance and progression. Oncogene 32:861-871
146. Nevins TA, Harder ZM, Korneluk RG, Holcik M (2003) Distinct regulation of internal ribosome entry site-mediated translation following cellular stress is mediated by apoptotic fragments of eIF4G translation initiation factor family members eIF4GI and p97/DAP5/NAT1. J Biol Chem 278:3572-3579
147. Ozes AR, Feoktistova K, Avanzino BC, Fraser CS (2011) Duplex unwinding and ATPase activities of the DEAD-box helicase eIF4A are coupled by eIF4G and eIF4B. J Mol Biol 412:674-687
148. Park EH, Zhang F, Warringer J, Sunnerhagen P, Hinnebusch AG (2011) Depletion of eIF4G from yeast cells narrows the range of translational efficiencies genome-wide. BMC Genomics 12:68
149. Patursky-Polischuk I, Stolovich-Rain M, Hausner-Hanochi M, Kasir J, Cybulski N, Avruch J, Ruegg MA, Hall MN, Meyuhas O (2009) The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor-or rictor-independent manner. Mol Cell Biol 29:640-649
150. Pavitt GD, Ron D (2012) New insights into translational regulation in the endoplasmic reticulum unfolded protein response. Cold Spring Harb Perspect Biol 4:a012278
151. Pelletier J, Sonenberg N (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325
152. Peltz SW, Morsy M, Welch EM, Jacobson A (2013) Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med 64:407-425
153. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC, Thomas G (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycinsensitive 5?-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24:3112-3124
154. Qin X, Sarnow P (2004) Preferential translation of internal ribosome entry site-containing mRNAs during the mitotic cycle in mammalian cells. J Biol Chem 279:13721-13728
155. Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, Polakiewicz RD, Sonenberg N, Hershey JW (2004) Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23:1761-1769
156. Redpath NT, Foulstone EJ, Proud CG (1996) Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J 15:2291-2297
157. Rogers GW Jr, Richter NJ, Lima WF, Merrick WC (2001) Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem 276:30914-30922
158. Rosenwald IB, Hutzler MJ, Wang S, Savas L, Fraire AE (2001) Expression of eukaryotic translation initiation factors 4E and 2alpha is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer 92:2164-2171
159. Rosenwald IB, Wang S, Savas L, Woda B, Pullman J (2003) Expression of translation initiation factor eIF-2alpha is increased in benign and malignant melanocytic and colonic epithelial neoplasms. Cancer 98:1080-1088
160. Rosenwald IB, Koifman L, Savas L, Chen JJ, Woda BA, Kadin ME (2008) Expression of the translation initiation factors eIF-4E and eIF-2 is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum Pathol 39:910-916
161. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N (1990) Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol 10:1134-1144
162. Rozovsky N, Butterworth AC, Moore MJ (2008) Interactions between eIF4AI and its accessory factors eIF4B and eIF4 H. RNA 14:2136-2148
163. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP (2004) The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10:484-486
164. Ruvinsky I, Meyuhas O (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31:342-348
165. Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, Dor Y, Zisman P, Meyuhas O (2005) Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 19:2199-2211
166. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10:389-402
167. Safaee N, Kozlov G, Noronha AM, Xie J, Wilds CJ, Gehring K (2012) Interdomain allostery promotes assembly of the poly(A) mRNA complex with PABP and eIF4G. Mol Cell 48:375-386
168. Schoenberg DR, Maquat LE (2012) Regulation of cytoplasmic mRNA decay. Nat Rev Genet 13:246-259
169. Shahbazian D, Parsyan A, Petroulakis E, Hershey J, Sonenberg N (2010a) eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways. Cell Cycle 9:4106-4109
170. Shahbazian D, Parsyan A, Petroulakis E, Topisirovic I, Martineau Y, Gibbs BF, Svitkin Y, Sonenberg N (2010b) Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B. Mol Cell Biol 30:1478-1485
171. Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE (2004) BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem 279:29066-29074
172. Shi Y, Frost PJ, Hoang BQ, Benavides A, Sharma S, Gera JF, Lichtenstein AK (2008) IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1. Cancer Res 68:10215-10222
173. Shimada A, Shiota G, Miyata H, Kamahora T, Kawasaki H, Shiraki K, Hino S, Terada T (1998) Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res 58:4434-4438
174. Shirokikh NE, Spirin AS (2008) Poly(A) leader of eukaryotic mRNA bypasses the dependence of translation on initiation factors. Proc Natl Acad Sci U S A 105:10738-10743
175. Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T et al (2000) Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 20:2489-2494
176. Siddiqi S, Matushansky I (2012) Piwis and piwi-interacting RNAs in the epigenetics of cancer. J Cell Biochem 113:373-380
177. Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, Hochman T, Formenti SC, Schneider RJ (2009) Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol 11:903-908
178. Sivan G, Aviner R, Elroy-Stein O (2011) Mitotic modulation of translation elongation factor 1 leads to hindered tRNA delivery to ribosomes. J Biol Chem 286:27927-27935
179. Smith L (2008) Post-transcriptional regulation of gene expression by alternative 5?-untranslated regions in carcinogenesis. Biochem Soc Trans 36:708-711
180. Somers J, Poyry T, Willis AE (2013) A perspective on mammalian upstream open reading frame function. Int J Biochem Cell Biol 45:1690-1700
181. Sonenberg N (2008) eIF4E, the mRNA cap-binding protein: from basic discovery to translational research. Biochem Cell Biol (Biochim Biol Cell) 86:178-183
182. Sontheimer EJ, Carthew RW (2005) Silence from within: endogenous siRNAs and miRNAs. Cell 122:9-12
183. Spriggs KA, Stoneley M, Bushell M, Willis AE (2008) Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell 100:27-38
184. Spriggs KA, Bushell M, Willis AE (2010) Translational regulation of gene expression during conditions of cell stress. Mol Cell 40:228-237
185. Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18:3112-3119
186. Stoecklin G, Kedersha N (2013) Relationship of GW/P-bodies with stress granules. Adv Exp Med Biol 768:197-211
187. Stoneley M, Paulin FE, Le Quesne JP, Chappell SA, Willis AE (1998) C-Myc 5? untranslated region contains an internal ribosome entry segment. Oncogene 16:423-428
188. Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane M, Willis AE (2000a) c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol Cell Biol 20:1162-1169
189. Stoneley M, Subkhankulova T, Le Quesne JP, Coldwell MJ, Jopling CL, Belsham GJ, Willis AE (2000b) Analysis of the c-myc IRES: a potential role for cell-type specific trans-acting factors and the nuclear compartment. Nucleic Acids Res 28:687-694
190. Stumpf CR, Ruggero D (2011) The cancerous translation apparatus. Curr Opin Genet Dev 21:474-483
191. Sun C, Todorovic A, Querol-Audi J, Bai Y, Villa N, Snyder M, Ashchyan J, Lewis CS, Hartland A, Gradia S et al (2011) Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3) Proc Natl Acad Sci U S A 108:20473-20478
192. Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, Marintchev A, Wagner G (2008) PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci U S A 105:3274-3279
193. Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, Belsham GJ, Sonenberg N (2001) The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5? secondary structure. RNA 7:382-394
194. Tejada S, Lobo MV, Garcia-Villanueva M, Sacristan S, Perez-Morgado MI, Salinas M, Martin ME (2009) Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors. J Histochem Cytochem 57:503-512
195. Terada T, Maeta H, Endo K, Ohta T (2000) Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling. Hum Pathol 31:817-821
196. Thedieck K, Holzwarth B, Prentzell MT, Boehlke C, Klasener K, Ruf S, Sonntag AG, Maerz L, Grellscheid SN, Kremmer E et al (2013) Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells. Cell 154:859-874
197. Thompson SR (2012) So you want to know if your message has an IRES? Wiley Interdiscip Rev RNA 3:697-705
198. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485:109-113
199. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515-524
200. van Gorp AG, van der Vos KE, Brenkman AB, Bremer A, van den Broek N, Zwartkruis F, Hershey JW, Burgering BM, Calkhoven CF, Coffer PJ (2009) AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B. Oncogene 28:95-106
201. Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 101:11269-11274
202. Villa N, Do A, Hershey JW, Fraser CS (2013) Human Eukaryotic Initiation Factor 4G (eIF4G) protein binds to eIF3c,-d, and-e to promote mRNA recruitment to the ribosome. J Biol Chem 288:32932-32940
203. Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ, Woda BA (1999) Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol 155:247-255
204. Wang S, Lloyd RV, Hutzler MJ, Rosenwald IB, Safran MS, Patwardhan NA, Khan A (2001a) Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma. Thyroid 11:1101-1107
205. Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG (2001b) Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 20:4370-4379
206. Warner JR, McIntosh KB (2009) How common are extraribosomal functions of ribosomal proteins? Mol Cell 34:3-11
207. Wells SE, Hillner PE, Vale RD, Sachs AB (1998) Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell 2:135-140
208. Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O (2007) Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep 18:1387-1393
209. Wethmar K, Smink JJ, Leutz A (2010) Upstream open reading frames: molecular switches in (patho)physiology. BioEssays 32:885-893
210. Wilkinson KA, Merino EJ, Weeks KM (2006) Selective 2?-hydroxyl acylation analyzed by primer extension (SHAPE): quantitative RNA structure analysis at single nucleotide resolution. Nat Protoc 1:1610-1616
211. Willig TN, Draptchinskaia N, Dianzani I, Ball S, Niemeyer C, Ramenghi U, Orfali K, Gustavsson P, Garelli E, Brusco A et al (1999) Mutations in ribosomal protein S19 gene and Diamond Blackfan anemia: wide variations in phenotypic expression. Blood 94:4294-4306
212. Wilson RC, Doudna JA (2013) Molecular mechanisms of RNA interference. Annu Rev Biophys 42:217-239
213. Yamashita R, Suzuki Y, Takeuchi N, Wakaguri H, Ueda T, Sugano S, Nakai K (2008) Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristics. Nucleic Acids Res 36:3707-3715
214. Yanagiya A, Suyama E, Adachi H, Svitkin YV, Aza-Blanc P, Imataka H, Mikami S, Martineau Y, Ronai ZA, Sonenberg N (2012) Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol Cell 46:847-858
215. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23:26-37
216. Zhang L, Pan X, Hershey JW (2007) Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282:5790-5800
217. Zhang L, Smit-McBride Z, Pan X, Rheinhardt J, Hershey JW (2008) An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3. J Biol Chem 283:24047-24060
218. Zhou C, Arslan F, Wee S, Krishnan S, Ivanov AR, Oliva A, Leatherwood J, Wolf DA (2005) PCI proteins eIF3e and eIF3 m define distinct translation initiation factor 3 complexes. BMC Biol 3:14
219. Zhou FF, Yan M, Guo GF, Wang F, Qiu HJ, Zheng FM, Zhang Y, Liu Q, Zhu XF, Xia LP (2011) Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells. Med Oncol 28:1302-1307